The State of Innovation in Europe

Europe’s drug innovative pipeline has reached a plateau, and is underexposed to high-growth areas such as oncology and cell & gene therapy. This paper reveals Europe’s current state of innovation, from pipeline constitution to emerging drug modalities, R&D alliances to financing trends.

Related resources

Biopharma professional on laptop browsing Pink Sheet for global policy and regulatory insights.
MAY 01, 2022
Regulatory & Compliance

Your Keys to Understanding EU Transparency

A collection of Pink Sheet articles covering evolving EU regulations on clinical trial disclosure and transparency

a person's hand holding a device with an AI interface
JUN 07, 2023

EU AI Act Legal Deep-Dive Part 1: What Can Medtech Expect, and When?

Members of the European Parliament voted in favor of substantial changes to the draft AI Act, which has since been passed into law.

JUL 13, 2023

EU AI Act Legal Deep-Dive Part 2: Balancing Medtech Innovation with Safety

As a horizontal regulation, the AI Act covers all sectors and uses of AI systems.